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The conjugation of arginine to proteins is a part of the N-end rule pathway of protein degradation. Three amino (N)-terminal residues-aspartate, glutamate and cysteine-are arginylated by ATE1-encoded arginyl-transferases. Here we report that oxidation of N-terminal cysteine is essential for its arginylation. The in vivo oxidation of N-terminal cysteine, before its arginylation, is shown to require nitric oxide. We reconstituted this process in vitro as well. The levels of regulatory proteins bearing N-terminal cysteine, such as RGS4, RGS5 and RGS16, are greatly increased in mouse ATE1 2/2 embryos, which lack arginylation. Stabilization of these proteins, the first physiological substrates of mammalian N-end rule pathway, may underlie cardiovascular defects in ATE1 2/2 embryos. Our findings identify the N-end rule pathway as a new nitric oxide sensor that functions through its ability to destroy specific regulatory proteins bearing N-terminal cysteine, at rates controlled by nitric oxide and apparently by oxygen as well.
The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue [1] [2] [3] [4] . A ubiquitin-dependent pathway, called the N-end rule pathway, recognizes degradation signals (degrons) that include the signals called N-degrons (Fig. 1a ). An N-degron consists of a protein's destabilizing N-terminal residue and an internal Lys residue. The latter is the site of formation of a polyubiquitin chain [5] [6] [7] [8] . The N-end rule has a hierarchic structure. N-terminal Asn and Gln are tertiary destabilizing residues in that they function through their deamidation, by N-terminal amidohydrolases 9, 10 , to yield the secondary destabilizing residues Asp and Glu. The activity of N-terminal Asp and Glu requires their conjugation, by ATE1-encoded isoforms of Arg-tRNA-protein transferase (R-transferase), to Arg, one of the primary destabilizing residues 11, 12 . The latter are recognized by E3 ubiquitin ligases of the N-end rule pathway 2, 4, 13, 14 . In mammals, destabilizing N-terminal residues that function through their arginylation are not only Asp and Glu but also Cys (Fig. 1a) , which is a stabilizing (unarginylated) residue in the yeast Saccharomyces cerevisiae 11, 12, 15 . Known functions of the N-end rule pathway include the control of peptide import (through conditional degradation of the import's repressor) 13, 16 , the regulation of apoptosis (through degradation of a caspase-processed inhibitor of apoptosis) 3, 17 and the fidelity of chromosome segregation (through degradation of a conditionally produced cohesin's fragment) 18 , as well as the regulation of meiosis, cardiovascular development in animals and leaf senescence in plants (refs 4, 12 and references therein).
Nitric oxide (NO) is produced in eukaryotes largely by NO synthases. This compound and its derivatives have a function, as either stressors or regulators, in a vast range of processes, including cardiovascular homeostasis, immunity, neurotransmission, ion conductance, glycolysis and apoptosis (reviewed in refs [19] [20] [21] [22] [23] [24] [25] [26] . Biological effects of NO are mediated by its covalent modifications of proteins, either of their prosthetic groups or amino-acid residues, particularly Cys and Tyr. The reactivity of these residues towards NO is modulated by their sequence contexts [20] [21] [22] [23] [27] [28] [29] . NO converts Cys residues to S-nitrosothiols, a process that can involve oxygen or its derivatives. S-Nitrosylation modulates protein functions either directly or after additional (often oxygen-dependent) transformations that yield oxidized Cys, such as Cys-sulphinic acid (CysO 2 H) or Cys-sulphonic acid (CysO 3 H) (refs 20-22) .
An N-degron is produced from pre-N-degron through a proteolytic cleavage. Methionine aminopeptidases (MetAPs) remove Met from the N terminus of a newly formed protein if, and only if, the residue at position 2, to be made N-terminal after cleavage, has a small enough side chain 2 . Consequently, of the 13 destabilizing residues of the mammalian N-end rule (Fig. 1a) , only Cys can be made N-terminal by MetAPs (Fig. 1b) . (Any destabilizing residue, including Cys, can be made N-terminal through internal cleavages of proteins by other proteases, such as separases, caspases and calpains 3, 17, 18 (Fig. 1a) .) Our previous work showed that Cys at position 2 of the RGS4 protein arginylated in vivo was CysO 3 H, rather than Cys, suggesting that the oxidation of N-terminal Cys might precede arginylation, and might be required for it 12 . We now show that oxidation of N-terminal Cys is essential for its arginylation. We also discovered that the oxidation of a protein's N-terminal Cys in vivo, before its arginylation, requires NO. This explains why N-terminal Cys is a destabilizing residue in mammalian cells 2, 12, 15 , which produce NO, but stabilizing in yeast 5 , which lack NO synthases. We reconstituted the NO-dependent arginylation of N-terminal Cys in an in vitro system as well. This process requires a basic residue at position 2 of a substrate. The levels of regulatory proteins with this N-terminal motif (Cys-(basic residue)), such as RGS4, RGS5 and RGS16, are greatly increased in mouse ATE1 2/2 embryos, which lack arginylation. RGS4, RGS5 and RGS16 are the first physiological substrates of the mammalian N-end rule pathway. Given the involvement of these proteins in cardiovascular homeostasis 30, 31 and tubulogenesis 32 , their stabilization might underlie the previously observed abnormal angiogenesis and heart defects in ATE1 2/2 embryos 12 . A mammalian genome encodes approx. 30 proteins, including RGS4, RGS5 and RGS16, that contain the Met-Cys-(basic residue) N-terminal motif, which acts as a MetAPcleaved, NO-dependent, arginylation-mediated, Cys-containing pre-N-degron. Taken together, our results identify the arginylation branch of the N-end rule pathway as a new sensor of NO in mammalian cells that functions through its ability to destroy specific regulatory proteins bearing N-terminal Cys, at rates controlled by NO and apparently by oxygen as well.
Oxidation of N-terminal cysteine is required for its arginylation
We wished to determine whether the presence of CysO 3 H (instead of Cys) at position 2 of the RGS4 protein arginylated in vivo 12 reflected the requirement for oxidation of Cys before its arginylation, as Figure 1 | N-terminal cysteine must be oxidized before its arginylation. a, The mammalian N-end rule pathway. N-terminal residues are indicated by single-letter abbreviations for amino acids. Yellow ovals denote the rest of a protein substrate. The 'cysteine' (Cys) sector, in the upper left corner, describes the main discovery of this work: the NO-mediated oxidation of N-terminal Cys, with subsequent arginylation of oxidized Cys by ATE1-encoded isoforms of R-transferase. C* denotes oxidized Cys, either Cys-sulphinic acid (CysO 2 H) or Cys-sulphonic acid (CysO 3 H). Type 1 and type 2 primary destabilizing N-terminal residues are recognized by E3 ubiquitin (Ub) ligases of the N-end rule pathway, including UBR1 and UBR2. Through their other substrate-binding sites these E3 ubiquitin ligases also recognize internal (non-N-terminal) degrons in other substrates of the N-end rule pathway, denoted by a larger yellow oval. b, MetAPs remove Met from the N terminus of a polypeptide if the residue at position 2 belongs to the set of residues shown. c-j, N-terminal Cys must be oxidized before its arginylation. Three eight-residue peptides are denoted as X-p; their N-terminal residues (X) were either Asp, Cys or CysO 3 H. X-p was incubated with mouse ATE1-1 R-transferase at pH 7.5 in the presence of ATP, S. cerevisiae Arg-tRNA synthetase and tRNAs, followed by analyses of peptide products, either by capillary electrophoresis (CE) (c-h) or by MALDI-TOF MS (i, j). The x and y axes (not shown) in CE patterns correspond, respectively, to the time of elution from CE column and A 200 . distinguished from oxidation of Cys after its arginylation. Three eight-residue XHGSGAWL peptides (where X represents Asp, Cys or CysO 3 H) were incubated with mouse ATE1-1 R-transferase 11 in the presence of ATP, S. cerevisiae Arg-tRNA synthetase and tRNAs. Both the Asp-peptide and the CysO 3 H-peptide were efficiently arginylated, whereas the Cys-peptide was not arginylated, as determined by capillary electrophoresis (compare Fig. 1c-f with Fig. 1g, h ), and confirmed, with regard to the identities of products, by matrixassisted laser desorption ionization-timeofflight (MALDI-TOF) MS (Fig. 1i, j) . The same results were obtained with S. cerevisiae ATE1 R-transferase 33 , a strong 'sequelogue' 34 of mammalian R-transferases 11 ( Supplementary Fig. S1 ). We conclude that the oxidation of N-terminal Cys is essential for its arginylation (Fig. 1c-j) .
Increased levels of RGS proteins in ATE1
2/2 embryos RGS4 is a GTPase-activating protein (GAP) for specific Ga subunits of G proteins and is a member of the family of RGS proteins that downregulate signalling by G proteins [30] [31] [32] [35] [36] [37] . Our earlier work showed that RGS4 (which begins, as a nascent protein, with Met-Cys) was a substrate of the N-end rule pathway in reticulocyte extract 38 . The levels of endogenous RGS4 were also increased by proteasome inhibitors 37 but the pathway of RGS4 degradation in vivo remained to be identified.
We compared the levels of endogenous RGS4 between 12.5-dayold (E12.5) wild-type mouse embryos and ATE1 2/2 embryos, which lacked R-transferases and therefore lacked arginylation 12 . The level of RGS4 in E12.5 ATE1 2/2 embryos was strikingly higher than in E12.5 wild-type embryos (Fig. 2a) . Similar results were obtained in pairwise comparisons of RGS4 in specific tissues from E14.5 wild-type and ATE1 2/2 embryos (Fig. 2b) . Two other members of the RGS family, RGS5 and RGS16, also bear N-terminal Cys. Experiments analogous to those with RGS4 revealed strong increases in RGS5 and RGS16 levels in ATE1 2/2 embryos (Fig. 2c-f ). These protein patterns (Fig. 2a-f) were not caused by increased levels of the corresponding Figure 2 | Strongly increased levels of RGS4, RGS5 and RGS16 proteins in ATE1 2/2 embryos. a, Lanes 1 and 2, equal amounts of total protein in extracts from wild-type (þ/þ) and ATE1 2/2 E12.5 embryos were fractionated by 12% SDS-PAGE, followed by immunoblotting with anti-RGS4 antibody. b, As in a but with extracts from the indicated tissues of wild-type and ATE1 2/2 E14.5 embryos. c, As in a but with anti-RGS5 antibody and E14.5 embryos. d, As in b but with anti-RGS5 antibody. e, As in a but with anti-RGS16 antibody. f, As in b but with anti-RGS16 antibody. (Fig. 2h, lanes 1-3) . These results indicated yet again, in a setting independent from that of ATE1 2/2 cells, that RGS16 was a substrate of the N-end rule pathway in vivo.
Decreasing NO in vivo stabilizes RGS4, RGS5 and RGS16 To examine the possibility that the oxidation of N-terminal Cys might involve NO, we constructed a mouse cell line, termed 3T3 toff RGS4 fh , that expressed RGS4-Flag-His 6 (RGS4 fh ) from a doxycycline-repressible promoter. Treatment of 3T3 toff RGS4 fh cells with N G -monomethyl-L-arginine (LMMA), an inhibitor of NO synthases (NOSs), markedly increased the level of RGS4 in vivo (Fig. 3a, compare lanes 2 and 4) . When 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO), a cell-penetrating NO scavenger, was used to decrease NO levels, the increase in RGS4 was even more striking (Fig. 3a , compare lanes 2 and 3, and lanes 7 and 8). In the experiments of Fig. 3a, lanes 1-4 and 9-11 , anti-RGS4 antibody detected two bands: the upper band's position was that expected for RGS4 fh ; the lower was apparently a proteolytic fragment of RGS4 fh , because changes in its levels paralleled those of full-length RGS4 fh . The lower band was not observed in an otherwise identical but independent experiment of Fig. 3a , lanes 7 and 8. In addition, the same anti-RGS4 antibody did not detect RGS4 in parental 3T3 toff cells (Fig. 3a, lanes 5 and 6) , and detected one RGS4 band in ATE1 2/2 embryos (Fig. 2a) .
Reverse-transcriptase-mediated polymerase chain reaction showed that 3T3 toff RGS4 fh cells expressed NOS1 (neuronal NOS) mRNA but little if any NOS2 (inducible NOS) and NOS3 (endothelial NOS) mRNAs (Supplementary Fig. S3 ). Given these findings, we also used an NOS inhibitor (N3411) that is highly selective for NOS1. In agreement with other NO results (Fig. 3a, lanes 1-8) , and despite the near-confinement of inhibition by N3411 to NOS1, this inhibitor substantially increased the levels of RGS4 (Fig. 3a, lanes  9-11) . We also examined whether RGS4 was elevated in NOS1 2/2 adult mice 24 . Despite the presence of NOS2 and NOS3 in these mice, RGS4 was strongly increased in the NOS1 2/2 lung, relative to the wild-type lung, and to a smaller extent in other tissues as well ( Supplementary Fig. S4 ).
To determine whether a decrease in NO concentration could affect the arginylation of RGS4 in vivo, we used N-terminal (Edman) sequencing. RGS4 fh purified from control 3T3 toff RGS4 fh cells was completely or nearly completely (more than 90%) arginylated in vivo (Fig. 3b) . In contrast, most RGS4 fh from cells that had been treated with cPTIO could not be sequenced by Edman degradation (Fig. 3b) . The identity of the blocking modification of RGS4 fh remains to be determined. Thus, RGS4 fh from cells with decreased NO was largely unarginylated (Fig. 3b) and therefore not a target of the N-end rule pathway, in agreement with other results (Fig. 3a) . In a pulse-chase assay, a negligible amount of 35 S-labelled RGS4 fh was present at the end of a 10-min pulse in untreated 3T3 toff RGS4 fh cells (Fig. 3d,  lanes 2-4) . In contrast, a strongly labelled band of RGS4 fh was observed with cPTIO-treated cells at the end of a 10-min pulse (Fig. 3d, compare lanes 2 and 5) . Although stabilized in cPTIOtreated cells, RGS4 fh remained partly unstable even in the presence of cPTIO (Fig. 3d, lanes 5-7) , which is consistent with the incomplete elimination of NO by cPTIO (refs 21, 22 and references therein).
RGS16 (but not RGS4) was naturally expressed in NIH-3T3 cells and in EF cell lines. Anti-RGS16 antibody detected trace amounts of RGS16 in untreated 3T3 cells but a much higher level of RGS16 after treatment with cPTIO (Fig. 3c, compare lanes 1 and 2) . Crucially, this effect of cPTIO was nearly absent when the same experiment was performed with ATE1 2/2 EF cells 12 , which lacked arginylation (Fig. 3c, compare lanes 3 and 4) , yielding independent evidence that the degradation of RGS16 requires both NO and arginylation. We also found that the level of RGS4 was much higher in 3T3 toff RGS4 fh cells grown under conditions of low (0.5%) oxygen concentration ( Fig. 2g ; see Discussion).
NO-dependent arginylation of RGS4 in vitro
Cys-RGS4, and also the otherwise identical Asp-RGS4 and Val-RGS4 (Fig. 1a) , were produced in Escherichia coli with the ubiquitin fusion technique 2 . X-RGS4 proteins were incubated with mouse ATE1-1 Rtransferase in the presence of ATP, [ 3 H]arginine, tRNA and other components of the analogous assay with eight-residue peptides (Fig. 1c-j) , except that arginylation of X-RGS4 was detected by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography. In addition to untreated controls, X-RGS4 proteins were also preincubated with one of two NO donors, either diglutathionyldinitroso-iron (DNIC-(GSH) 2 , a physiologically relevant NO carrier 39, 40 ) or diethylenetriamine/nitric oxide adduct (DETA-NO). The results indicated an almost complete dependence of the arginylation of Cys-RGS4 in vitro on its previous exposure to a donor of NO (Fig. 4 , compare lane 4 with lanes 5 and 6). (Dissolved oxygen and other gases were at levels that are normally present in buffers.) In contrast, Asp-RGS4 was efficiently arginylated irrespective of pretreatment with NO, and Val-RGS4 was not arginylated (Fig. 4) . Thus, the NO dependence of in vivo arginylation of proteins bearing N-terminal Cys (Figs 2 and 3) can be reconstituted in an in vitro system (Fig. 4) .
Sequence motif of NO-dependent N-degron The advances described above (Figs 1-4) accounted for the following, previously unexplained, observation: the conversion of the position 3 residue of RGS4 (position 2 after Met removal) from basic Lys to uncharged Ser stabilized the resulting RGS4 K3S against degradation in a reticulocyte extract 38 . In contrast, RGS4 K3R , in which Lys 2 was replaced by Arg, remained short-lived 38 . Moreover, in contrast to wild-type RGS4, which was arginylated and bore CysO 3 H at position 2 ( Fig. 3d and ref. 12 ), RGS4 K3S that was transiently expressed in 1-3) , Cys-RGS4 (lanes 4-6) and Val-RGS4 (lanes 7-9) were incubated with [ 3 H]arginine under conditions of the arginylation assay described in the text, followed by SDS-PAGE and fluorography. Lanes 1, 4 and 7, no pretreatment of X-RGS4 proteins. Lanes 2, 5 and 8, pretreatment of X-RGS4 proteins with DETA-NO. Lanes 3, 6 and 9, pretreatment of X-RGS4 proteins with DNIC-[GSH] 2 . The asterisk denotes a minor 3 H-labelled species whose apparent molecular mass and relative levels indicate that it might be a dimer of X-RGS4. mouse cells was found to have a blocked N terminus (I. Davydov and A.V., unpublished observations). These results can now be explained, because S-nitrosylation of internal (non-N-terminal) Cys by NO in polypeptides depends, in particular, on the presence of a Cys-proximal basic residue, which facilitates the abstraction of H þ from the cysteine's thiol group 21, 22 . In agreement with this explanation, the second residues of MetAP-processed RGS4, RGS5 and RGS16 are Lys, Lys and Arg, respectively. In a different examination of the consensus motif (N-terminal Cys-(basic residue)), we used an antibody against serine racemase 20 , a protein with a Cys-Ala N-terminal sequence, to examine whether the levels of racemase were increased in ATE1 2/2 embryos or UBR1/2 dnR2 cells. In contrast to results with RGS4, RGS5 and RGS16, no significant changes in racemase levels were observed (Fig. 2h, lanes 4-8) , as would be expected from the requirement for a basic residue at position 2 for efficacious NO-mediated oxidation of N-terminal Cys.
Discussion
We have shown here that the oxidation of N-terminal Cys in a polypeptide is essential for the arginylation of Cys by ATE1-encoded R-transferases (Fig. 1c-j) . We also discovered that the arginylation branch of the N-end rule pathway (Fig. 1a) is a sensor of nitric oxide (NO) that functions through its ability to destroy specific regulatory proteins bearing N-terminal Cys, at rates controlled by NO and apparently by oxygen as well (Figs 2-4) . The first examples of these regulators, RGS4, RGS5 and RGS16, are also the first physiological substrates of mammalian N-end rule pathway. These proteins downregulate specific a subunits of G proteins by increasing their GTPase activity [30] [31] [32] [35] [36] [37] . Through the conditional destruction of RGS4, RGS5 and RGS16, the N-end rule pathway is therefore involved in the regulation of signalling by G-protein-coupled receptors.
The above 'unification' of a ubiquitin-dependent proteolytic pathway and NO signalling opens up new vistas for understanding both. Most of the previously known regulation by NO was based on changes in the functional (for example enzymatic) activity of NO-modified proteins [19] [20] [21] [22] [23] [27] [28] [29] . In contrast, a Cys-containing N-degron of a protein makes possible the NO-mediated control of circuits that contain this protein, through its NO-dependent degradation by the N-end rule pathway. The observed stabilization of RGS4 in cells grown at low oxygen concentration (Fig. 2g) suggests a possible involvement of oxygen or its derivatives in this NO-dependent regulation. That would also be expected from the NO results alone (Figs 3 and 4) , given multiple links between the chemistries of NO and oxygen in vivo [19] [20] [21] [22] [23] . Our assay in vitro for NO-dependent arginylation of N-terminal Cys (Fig. 4) should eventually yield a detailed understanding of chemical transformations that result in oxidation of this uniquely positioned Cys residue.
The pathway of control by NO (Fig. 1a) targets proteins that bear N-terminal Cys followed by a basic residue. This motif is present in about 30 proteins encoded by the mouse (and human) genome, including RGS4, RGS5 and RGS16. More than half of non-RGS proteins in this set have entirely unknown functions, and the rest are barely characterized. The N-terminal Cys residues of RGS4, RGS5 and RGS16 can also be modified through palmitoylation 36 . The two modifications are expected to be mutually exclusive and also act in opposite ways, in that palmitoylation increases the activity of RGS proteins as downregulators of G proteins 36 , whereas NO-dependent arginylation and destruction of RGSs reduce their activity by decreasing their levels in a cell.
RGS4 is a physiological inhibitor of angiogenesis and other tubulogenesis pathways 32 . Upregulation of RGS4 perturbs cardiovascular homeostasis in mice 31 and is a molecular correlate of human heart failure 30 . Mouse ATE1 2/2 embryos, which lack R-transferases and therefore lack arginylation, die before E17 with cardiovascular defects 12 . Our findings that the levels of RGS4, RGS5 and RGS16 are greatly increased in the hearts and other organs of ATE1 2/2 embryos (Fig. 2) , and that NO is required for the proteolytic downregulation of these RGSs (Figs 3 and 4) , are likely to account in part for the known role of NO, at physiologically optimal levels, in suppressing pathological changes in the heart 25, 26, 41 . The functions of NO in cardiovascular homeostasis include the stimulation of cyclic GMP formation by guanylyl cyclase and the regulation of cardiac contractility through S-nitrosylation of the calcium release channel 21, 23, 41 . Our results revealed an entirely different, mutually nonexclusive mechanism of NO signalling in the heart and other organs: the control of regulatory proteins bearing N-terminal Cys through their NO-dependent, arginylation-mediated degradation by the N-end rule pathway. Thus, pharmacological manipulation of activities or expression of R-transferases may provide an alternative, more selective route to clinically beneficial effects that are currently achieved through drugs that alter the levels of NO.
Mammalian R-transferases are strong sequelogues 34 of yeast (fungal) ATE1 R-transferases. However, whereas the inactivation of mouse ATE1 results in embryonic lethality 12 , a deletion of S. cerevisiae ATE1 renders cells unable to degrade reporters with N-terminal Asp or Glu but has not been found to cause any other abnormal phenotype 2, 33 . Our findings indicate that one function of arginylation in this and other organisms might be to serve as a sensor of nitrosative/oxidative stress (Supplementary Information). It remains to be determined whether the discovered signalling by NO proceeds exclusively through the oxidation of Cys-containing N-degrons (Fig. 1a) or whether NO can also function at other steps of the N-end rule pathway, for example through S-nitrosylation of its ubiquitin ligases or R-transferases.
A preponderance of circuits relevant to the findings of this work involve arginine: first, Arg is a direct precursor of NO (Fig. 1a) ; second, the levels of Arg are tightly controlled in a cell and are often downregulated by invading pathogens; third, Arg is a part of Arg-tRNA (a co-substrate of R-transferase), indicating a possible connection between the N-end rule pathway and regulation of translation; fourth, Arg is a primary destabilizing residue and is also conjugated to N-end rule substrates bearing N-terminal Asp, Glu or oxidized Cys (Fig. 1a) ; and last, some Arg residues in proteins undergo methylation or deimination, the latter a conversion of positively charged Arg to uncharged citrulline 42, 43 . It remains to be determined whether methylation or deimination of Arg in vivo involves N-terminal Arg, and whether a set of circuits that has now been shown to connect the N-end rule pathway and the signalling by NO holds yet another Arg-linked surprise.
METHODS
Full technical details are provided in Supplementary Information. Mouse embryos, immunoblotting and northern hybridization. ATE1 2/2 and wild-type embryos were produced as described 12 . E12.5 and E14.5 whole embryos or their organs were collected, followed by immunoblotting of embryo extracts with antibodies against RGS4 (a gift from S. Mumby), RGS16 (a gift from C. K. Chen and M. Simon), RGS5 (a gift from M. Greenwood), serine racemase (BD Biosciences), and mouse ATE1-1 R-transferase. The latter antibody was raised in rabbits against purified ATE1-1.
3T3
toff RGS4 fh , other cell lines, and treatments. Treatments of cells with cPTIO, with LMMA or with N3411 (L-N q -nitroarginine-2,4-L-diaminobutyric amide) were performed as described in Supplementary Information, followed by the preparation of extracts, SDS-PAGE and immunoblotting. The mouse 3T3 toff RGS4 fh cell line, which expressed RGS4-Flag-His 6 (RGS4 fh ) from a doxycycline-repressible promoter, was constructed with MEF/3T3 'Tet-off ' cells (BD Biosciences). Other mouse cell lines were UBR1/2 dnR2 (see the text; J.S., Z. Xia, Y. T. Kwon and A.V., unpublished observations), ATE1 2/2 EF cells and NIH-3T3 cells. Pulse-chase experiments were performed with 3T3 toff RGS4 fh cells, essentially as described 12 . Reporter peptides and recombinant proteins. The eight-residue Asppeptide (DHGSGAWL) and Cys-peptide (CHGSGAWL) were synthesized by standard methods. CysO 3 H-peptide was synthesized as described in Supplementary Information. S. cerevisiae Arg-tRNA synthetase (RRS1) was expressed in E. coli and purified by chromatography. S. cerevisiae ATE1 R-transferase 33 was carboxy-terminally tagged with His 6 , expressed in E. coli and purified
